To establish an operational presence in the U.S., reinsurance broker Willis Re on Aug. 18 said it is acquiring BMS Re, US.
The deal includes BMS Intermediaries Inc. and BMS Capital Advisory LLC, as well as the associated US reinsurance broking team based in London. Terms were not disclosed.
Independent reinsurance platform BMS Re, US, part of BMS Group, is focused on property/casualty, with expertise in complex lines including property ca
tastrophe, medical malpractice and workers’ compensation. It offers reinsurance and capital solutions with local market expertise, and a strong client base across regional and superregional carriers, and MGA and programs.
“This is a transformational acquisition for Willis Re and one that strongly supports our global growth strategy and greatly accelerates our expansion into the US,” said Lucy Clarke, Willis Re board member, in a statement.
“Combined with Willis Re’s existing specialty expertise and international platform, we are extremely well positioned to deliver exceptional outcomes for clients and pursue attractive long-term growth opportunities,” Clarke added.
Watch More Image Part 2 >>>
BMS Group said the agreement excludes the UK, Latin America, Bermuda, and Global Facultative business, which remain a core component of the brokerage.
BMS Group CEO Nick Cook said the transaction is :an important step in BMS’s ongoing evolution” and Willis Re is “the right partner” to take its US reinsurance business further.
2025 included the first ever federal nuclear verdict against a marijuana company, another from an antitrust case from basketball great Michael Jordan against NASCAR, and a $40 million RICO award against an internet troll posing as a government spy, Marathon observed.
Overall, 68 industries were affected by a nuclear verdict in 2026 compared with 55 in 2024 and 48 in 2023. Among the most familiar with nuclear verdicts are beverage companies, pharmaceuticals, auto manufacturers, hotels a
nd restaurants, agricultural chemical manufacturers, banks, and oil and gas. Insurance had five nuclear verdicts for a sum of $390 million.
Product liability cases resulted in 29 nuclear verdicts totaling $12 billion in 2025. Trade-secret dis
putes, intellectual-property cases, and workplace negligence also had a large share of nuclear cases. New possible areas of risk are emerging such as PFAS, AI liability, deepfakes, and climate attribution, among others.